Targets for Alzheimer's disease: Lessons learnt from flies

M. Konsolaki, D. Cohen

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Neurodegenerative diseases, including Alzheimer's disease (AD), are a major focus of the pharmaceutical industry. Recently, human genetic analyses have aided in the successful identification of a handful of genes responsible for genetically inherited forms of AD, but our understanding of basic mechanisms that lead to the more common sporadic forms of this disease is still limited.

Original languageEnglish (US)
Pages (from-to)64-70
Number of pages7
JournalDrug Discovery Today: TARGETS
Volume3
Issue number2
DOIs
StatePublished - Apr 1 2004
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Drug Discovery

Keywords

  • Alzheimer's Disease
  • Drosophila
  • Drug Discovery
  • Genetics
  • Molecular Medicine
  • Neurobiology
  • Pharmaceutical Science
  • beta-amyloid
  • disease pathways
  • genetic analysis

Fingerprint Dive into the research topics of 'Targets for Alzheimer's disease: Lessons learnt from flies'. Together they form a unique fingerprint.

Cite this